BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Africa/Lagos
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0100
TZNAME:WAT
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211005T120000
DTEND;TZID=America/New_York:20211005T153000
DTSTAMP:20210924T193824Z
CREATED:20210924T193720Z
LAST-MODIFIED:20210924T193824Z
UID:49771-1633435200-1633447800@globalbiodefense.com
SUMMARY:Improving Diversity of the Genomics Workforce: A Workshop
DESCRIPTION:The Roundtable on Genomics and Precision Health will host a virtual public workshop that will examine the current state of diversity (e.g.\, racial\, ethnic) of the genetics and genomics workforce\, structural issues that have contributed to diversity challenges\, and potential steps forward. Workshop discussions may address topics such as the impact of racism on the culture of the fields of genetics and genomics; how the genetics/genomics workforce is or is not uniquely affected by structural racism; and the relationship between the lack of diversity in the workforce and patient access to genetic services. \nPanelists will be asked to discuss structural challenges impeding workforce diversity in clinical genetics/genomics\, current efforts to improve workforce diversity in the field\, how those efforts might improve access for patients from underrepresented groups\, and opportunities for professional societies and associations to better support the training and integration of providers from diverse backgrounds. A proceedings in brief of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. \nBACKGROUND \nThe sequencing of the human genome is rapidly opening new doors to research and progress in biology\, medicine\, and health care. At the same time\, these developments have produced a diversity of new issues to be addressed. The National Academies of Sciences\, Engineering\, and Medicine has convened a Roundtable on Genomics and Precision Health (previously the Roundtable on Translating Genomic-Based Research for Health) that brings together leaders from academia\, industry\, government\, foundations and associations\, and representatives of patient and consumer interests who have a mutual concern and interest in addressing the issues surrounding the translation of genome- based research for use in maintaining and improving health. The mission of the Roundtable is to advance the field of genomics and improve the translation of research findings to health care\, education\, and policy. \nThe Roundtable will discuss the translation process\, identify challenges at various points in the process\, and discuss approaches to address those challenges. The field of genomics and its translation involves many disciplines\, and takes place within different economic\, social\, and cultural contexts\, necessitating a need for increased communication and understanding across these fields. As a convening mechanism for interested parties from diverse perspectives to meet and discuss complex issues of mutual concern in a neutral setting\, the Roundtable: fosters dialogue across sectors and institutions; illuminates issues\, but does not necessarily resolve them; and fosters collaboration among stakeholders. To achieve its objectives\, the Roundtable conducts structured discussions\, workshops\, and symposia. Workshop summaries will be published and collaborative efforts among members are encouraged (e.g.\, journal articles). \nSpecific issues and agenda topics are determined by the Roundtable membership\, and span a broad range of issues relevant to the translation process. Issues may include the integration and coordination of genomic information into health care and public health including encompassing standards for genetic screening and testing\, improving information technology for use in clinical decision making\, ensuring access while protecting privacy\, and using genomic information to reduce health disparities. The patient and family perspective on the use of genomic information for translation includes social and behavioral issues for target populations. There are\nevolving requirements for the health professional community\, and the need to be able to understand and responsibly apply genomics to medicine and public health. \nOf increasing importance is the need to identify the economic implications of using genome-based research for health. Such issues include incentives\, cost-effectiveness\, and sustainability. \nIssues related to the developing science base are also important in the translation process. Such issues could include studies of gene-environment interactions\, as well as the implications of genomics for complex disorders such as addiction\, mental illness\, and chronic diseases. \nLinks to Additional Resources \n\nBonham & Green\, 2021. The genomics workforce must become more diverse: a strategic imperative. The American Journal of Human Genetics 108(1): 3-7.\nChannaoui et al. 2020. Summary report of the 2019 Diversity and Inclusion Task Force of the National Society of Genetic Counselors. Journal of Genetic Counseling 29(2):192-201.\nMann\, S. 2020. Creation of the Minority Genetic Professionals Network to increase diversity in the genetics work force.\nRotenstein et al. 2021. Addressing workforce diversity – A quality-improvement framework. The New England Journal of Medicine. 384: 1083-1086.\nASHG 2021 Meeting- Session on workforce diversity in genomics: Equity and the meaning of inclusion.
URL:https://globalbiodefense.com/event/improving-diversity-of-the-genomics-workforce-a-workshop/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211005T140000
DTEND;TZID=America/New_York:20211006T170000
DTSTAMP:20210923T214504Z
CREATED:20210923T214504Z
LAST-MODIFIED:20210923T214504Z
UID:49734-1633442400-1633539600@globalbiodefense.com
SUMMARY:From Molecular Insights to Patient Stratification
DESCRIPTION:On October 5-6\, 2021\, the Forum on Neuroscience and Nervous System Disorders will host a virtual public workshop that brings together experts and key stakeholders from academia\, industry\, government\, philanthropic foundations\, and disease-focused non-profit organizations to discuss new genetic and neuroscience technologies and explore how these discoveries can be used to elucidate disease mechanisms and to advance the development of biomarkers and targeted therapies for patients with neurological and psychiatric disorders. \nInvited presentations and discussions will be designed to: \n\nExplore the critical need for ancestral diversity and inclusion of individuals with severe or less common disorders—in genetics and the biological specimens needed to follow up on genetics—to advance both scientific analyses and global health equity/precision medicine.\nExamine the use of genetics and other technologies to facilitate identification of genetic variation\, understand the effects of both common and rare variants on disease relevant function\, and gain insights into disease mechanisms and molecular pathways in order to identify biomarkers that enable patient stratification to advance therapeutic development.\nHighlight lessons learned from recent advances in disorders associated with rare\, penetrant genetic variants\, and explore how resulting lessons can be applied to more common neuropsychiatric disorders.\nExplore challenges and promising approaches to nominating and validating stratification\, disease progression\, and treatment biomarkers.\nExplore challenges of designing innovative clinical trials that are based on deep mechanistic understanding of diseases and coupled with target engagement strategies in patients.\nDiscuss a conceptual structure and opportunities to enable advanced technologies and computational approaches to be used more broadly\, effectively\, and rationally for new disorders\, including considering data sharing and stakeholder engagement.\n\nWorkshop Background \nSignificant progress has been seen recently in developing therapies for rare monogenetic disorders such as spinal muscular atrophy and Dravet syndrome. In this domain there is strong collaboration and interest across the R&D landscape\, from academia to biopharma and venture capital. Significant progress has also been seen in fields such as cardiovascular medicine and cancer in improving patient stratification and developing targeted drugs based on genetic findings. In contrast\, progress continues to lag for neuropsychiatric disorders where critical challenges include insufficient mechanistic insights and a lack of biomarkers that can be used to stratify patients within broad symptom-based diagnostic categories. In addition\, minority populations have been largely excluded or underrepresented in genetic studies and clinical trials\, which has been an obstacle in development of appropriate treatments for diverse populations. \nIn the past several years\, there have been important advances in genetic and neuroscience technologies and approaches that have great potential for improving mechanistic understanding of neuropsychiatric diseases and support the development of biomarkers. These include mechanistic and translational studies in patient-derived cells and tissues (iPS derived neurons\, glia\, organoids); high throughput means to analyze combinations of genetic variants; and other tools and computational approaches\, including those developed as part of the BRAIN Initiative. Alongside these technical advances\, it will be critical to increase the ancestral diversity in emerging precision medicine for neuropsychiatric disorders. The time is ripe to explore how these technologies and approaches can be used in the development of biomarkers for patient stratification\, with the ultimate goal of advancing translational efforts and clinical development for rare and common brain disorders.
URL:https://globalbiodefense.com/event/from-molecular-insights-to-patient-stratification/
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/09/4863f9d63397e0dfe8c5dcf992536c49.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211006T140000
DTEND;TZID=America/New_York:20211006T153000
DTSTAMP:20210924T031819Z
CREATED:20210924T031819Z
LAST-MODIFIED:20210924T031819Z
UID:49760-1633528800-1633534200@globalbiodefense.com
SUMMARY:Incorporating Lessons Learned During COVID-19 into Future Planning for Emergencies and Disasters
DESCRIPTION:The COVID-19 pandemic has created unprecedented challenges for disaster planners and responders\, bringing to light both shortfalls and opportunities. The rapid pace of operations and ongoing evolution of the public health emergency have prompted modifications to plans and procedures in emergency response; however\, many of the leaders within local and state agencies involved in these activities have not yet had an opportunity to reflect on lessons learned or to incorporate them into emergency plans and mitigation strategies. \nThe observed impacts of the pandemic itself\, as well as other disasters that have intersected with it\, have also shined a light on the deep inequities that contribute to and reproduce unjust outcomes among marginalized communities. \nHow do use what we’ve learned since the appearance of the novel coronavirus to create more equitable and just systems that support the whole community? What steps can we take to better equip disaster preparedness systems to respond to this ongoing threat and future emergencies? This webinar will bring together perspectives from emergency management\, public administration\, public health\, and disaster science to discuss lessons learned from the COVID-19 pandemic and how those lessons can inform future planning for emergencies and disasters. \nModerator: \nNnenia Campbell\, Research Associate\, Natural Hazards Center \nPanelists: \n\nJeffrey Schlegelmilch\, Director\, National Center for Disaster Preparedness\nCurtis Brown\, State Coordinator\, Virginia Department of Emergency Management\nDonell Harvin\, Senior Homeland Security Researcher\, Defense and Political Science\, RAND Corporation\nLeila Darwish\, Independent Community Organizer and Bioremediation Educator\n\nPlease visit NASEM’s Incorporating Lessons Learned During COVID-19 into Future Planning for Emergencies and Disasters meeting page for more information. \n 
URL:https://globalbiodefense.com/event/incorporating-lessons-learned-during-covid-19-into-future-planning-for-emergencies-and-disasters/
CATEGORIES:Conference
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211006T150000
DTEND;TZID=America/New_York:20211006T170000
DTSTAMP:20210924T211020Z
CREATED:20210924T211020Z
LAST-MODIFIED:20210924T211020Z
UID:49774-1633532400-1633539600@globalbiodefense.com
SUMMARY:Respiratory Protection for the Public and Workers without Respiratory Protection Programs at their Workplaces
DESCRIPTION:This is the eighth virtual meeting of a consensus study focused on respiratory protection for the public and workers without respiratory protection programs. During the public portion of this meeting\, the committee will explore current processes and systems for evaluating infectious agents transmissible by inhalation routes and determining the need for public use of respiratory protective devices. \nThe discussion will be led by: \n\nJONATHAN SAMET\, Committee Chair Dean and Professor\, Colorado School of Public Health\nCAPT LISA DELANEY\, Associate Director\, Emergency Preparedness and Response Program\, National Institute for Occupational Safety and Health\nMICHAEL BELL\, Deputy Director\, Division of Healthcare Quality Promotion\, Centers for Disease Control and Prevention\n\nLearn more at NASEM’s Respiratory Protection for the Public and Workers without Respiratory Protection Programs at their Workplaces meeting page. \n 
URL:https://globalbiodefense.com/event/respiratory-protection-for-the-public-and-workers-without-respiratory-protection-programs-at-their-workplaces/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211007T094500
DTEND;TZID=America/New_York:20211007T140000
DTSTAMP:20210925T035750Z
CREATED:20210925T035750Z
LAST-MODIFIED:20210925T035750Z
UID:49811-1633599900-1633615200@globalbiodefense.com
SUMMARY:COVID-19 Vaccines: A Global Experts' Summit
DESCRIPTION:Hear from researchers and public health experts on present and future scenarios as they explore the changing landscape of the virus\, including the Delta variant’s impact on children\, and the latest in vaccine availability\, hesitancy and boosters. \nThis is the last in a series of three virtual events\, hosted by Florida International University in partnership with Baylor College of Medicine\, focusing on the most prevailing issues around COVID-19 and the challenges to preserve global health. \nPlease visit the COVID-19 Vaccines: A Global Experts’ Summit website for more information.
URL:https://globalbiodefense.com/event/covid-19-vaccines-a-global-experts-summit/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20211007T183000
DTEND;TZID=Europe/London:20211007T193000
DTSTAMP:20210925T034618Z
CREATED:20210925T034618Z
LAST-MODIFIED:20210925T034618Z
UID:49808-1633631400-1633635000@globalbiodefense.com
SUMMARY:Poxvirus Research After Smallpox Eradication: New Findings With An Old Vaccine
DESCRIPTION:In 1980 smallpox was declared eradicated after a global vaccination campaign. Today\, only two labs in the world retain variola virus\, the cause of smallpox\, one in the USA and one in Russia – and the World Health Assembly has recommended these virus stocks be destroyed when essential research with variola virus is complete. \nProfessor Geoffrey L. Smith FRS\, winner of the 2020 Leeuwenhoek Medal\, will describe how smallpox was eradicated and what happened afterwards. Despite eradication\, research with vaccinia virus\, the smallpox vaccine\, has endured. This research has provided new ways to make vaccines\, and revealed how our cells respond to virus infection and how the virus escapes these defenses. \nAttending this event\nThis lecture was originally scheduled for March 2020 and has now been rescheduled to take place online. \nLearn more about the Poxvirus Research After Smallpox Eradication: New Findings With An Old Vaccine lecture at The Royal Society website. Register for this event on Eventbrite.
URL:https://globalbiodefense.com/event/poxvirus-research-after-smallpox-eradication-new-findings-with-an-old-vaccine/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211013T173000
DTEND;TZID=America/New_York:20211013T183000
DTSTAMP:20210930T222721Z
CREATED:20210930T215922Z
LAST-MODIFIED:20210930T222721Z
UID:49957-1634146200-1634149800@globalbiodefense.com
SUMMARY:The Future of Global Health Security
DESCRIPTION:Join faculty members from the Schar School’s Biodefense master’s program in a discussion on the future of global health security considering lessons learned from the COVID-19 pandemic. \nPolicy Exchange: The Future of Global Health Security will take place Wednesday\, October 13\, 2021 at 5:30 p.m. ET in a virtual format. This event highlights faculty from GMU Schar School’s Master’s in Biodefense program\, but all prospective students are invited to attend. \nThe COVID-19 pandemic revealed unexpected weaknesses in our preparedness for pandemic threats\, and it continues to pose serious challenges around the world. How are health authorities in the United States and around the world trying to reduce these vulnerabilities so we are better equipped for the next pandemic? \nABOUT THE PANEL \nAdjunct Professor Ashley Grant\, a lead biotechnologist at the MITRE Corporation\, previously served as the senior biological scientist at the Government Accountability Office where she led government-wide technical performance audits focused on biosafety and biosecurity issues. She was an American Association for the Advancement of Science (AAAS) Science and Technology Fellow in the Chemical and Biological Defense Program Office in the Department of Defense and worked at the National Academies of Science on the Committee on International Security and Arms Control. \nAdjunct Professor Andrew Kilianski is the chief intelligence officer for the Department of Defense’s Joint Program Executive Office for Chemical\, Biological\, Radiological and Nuclear Defense (JPEO-CBRND). His work focuses on combating weapons of mass destruction and infectious diseases\, counterintelligence threats to the DoD’s Chemical and Biological Defense Program\, and emerging threat characterization and assessment. Previously\, he served as the CBRN Defense Team Lead at the Defense Intelligence Agency – National Center for Medical Intelligence where he led a team of analysts covering worldwide WMD and medical science and technology developments. \nTerm Assistant Professor Saskia Popescu recently created and disseminated a gap analysis for a six-hospital system to establish vulnerabilities for high-consequence diseases\, helping to guide the creation of a high-consequence disease initiative to enhance readiness at the health care level. This work aided in rapid and coordinated responses to COVID-19. Popescu is certified in infection prevention (CIC)\, hospital preparedness through FEMA’s NIMS\, and pandemic preparedness from the DHS Center for Domestic Preparedness. She currently serves as a member of the Federation of American Scientists (FAS) Coronavirus Taskforce and is a member of the Committee on Data Needs to Monitor Evolution of SARS-CoV-2 within the Health and Medicine Division of the National Academies of Sciences\, Engineering\, and Medicine (NASEM). \nPlease visit the Schar School’s Policy Exchange: The Future of Global Health Security page for more information.
URL:https://globalbiodefense.com/event/gmu-biodefense-future-of-global-health-security-2/
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/09/gmu-biodefense-future-global-health-security-event-banner-lg.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211014
DTEND;VALUE=DATE:20211016
DTSTAMP:20211004T005916Z
CREATED:20211004T005916Z
LAST-MODIFIED:20211004T005916Z
UID:50034-1634169600-1634342399@globalbiodefense.com
SUMMARY:VRBPAC Meeting on Janssen and Moderna COVID-19 Vaccine Boosters
DESCRIPTION:On Oct. 14 and 15\, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet to discuss the use of booster doses of the Moderna COVID-19 Vaccine and the Janssen COVID-19 Vaccine. Both vaccines are currently authorized for emergency use to prevent COVID-19 in individuals 18 years of age and older. The committee will also hear presentations and discuss the available data on the use of a booster of a different vaccine than the one used for the primary series of an authorized or approved COVID-19 vaccine (heterologous or “mix and match” booster). \nOn Oct. 14\, the committee will discuss an amendment to the emergency use authorization of the Moderna COVID-19 Vaccine for the administration of a booster dose\, in individuals 18 years of age and older. \nOn Oct. 15\, the VRBPAC will discuss amending the emergency use authorization of Johnson and Johnson’s Janssen COVID-19 Vaccine for the administration of a booster dose\, in individuals 18 years of age and older. \nAdditionally\, on Oct. 15\, the committee will hear a presentation from the National Institute of Health’s National Institute of Allergy and Infectious Diseases on the heterologous use of booster doses following the primary series of the three currently authorized or approved COVID-19 vaccines. \nDuring the meeting\, the committee will hear presentations from the companies on the data for their respective vaccines. The FDA will also present its own analyses of each of the manufacturers’ data. There will be an open public hearing each day during which the public will be given an opportunity to provide comments. \nThe FDA intends to make background materials for both VRBPAC meetings available to the public\, including the meeting agendas and committee rosters\, no later than two business days before each meeting. \nThe FDA intends to livestream the VRBPAC meetings on the agency’s YouTube page.
URL:https://globalbiodefense.com/event/vrbpac-meeting-on-janssen-and-moderna-covid-19-vaccine-boosters/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/10/fda-vrbpac-mix-match-booster-shots-janssen-moderna-boosters-covid-19.jpg
LOCATION:https://www.youtube.com/watch?v=BhlshZ7Lkr0
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211014T110000
DTEND;TZID=America/New_York:20211014T120000
DTSTAMP:20210924T211921Z
CREATED:20210924T211756Z
LAST-MODIFIED:20210924T211921Z
UID:49776-1634209200-1634212800@globalbiodefense.com
SUMMARY:Protecting Health Care in Zones of Conflict: A Webinar
DESCRIPTION:Panelists Leonard Rubenstein (author of the recently released Perilous Medicine: The Struggle to Protect Health Care from the Violence of War) and Joanne Liu will discuss attacks on health workers\, patients\, and hospitals in conflict settings around the world\, along with urgent actions that need to be taken to help ensure safe access to and delivery of health care. The discussion will be moderated by Robert Lawrence. \nSpeakers: \nJoanne Liu\, Professor at the School of Population and Global Health\, McGill University and former International President\, Me´decins Sans Frontie`res \nDr. Joanne Liu has served as International President of Médecins Sans Frontières (MSF) from 2013 to 2019. At the helm of MSF\, she has been a leading voice on medical humanitarian crises\, namely in the Ebola outbreak of West Africa and attacks on hospitals and forced displacement crises\, and has engaged with world leaders at the highest levels. Dr. Liu’s role builds on a career of field work with MSF\, including over 20 medical-humanitarian field assignments. Dr. Liu trained at McGill University School of Medicine in Montreal. She holds a Fellowship in Pediatric Emergency Medicine from New York University School of Medicine and an International Master’s in Health Leadership\, also from McGill University. Dr. Liu’s operational work has ranged from introducing comprehensive care for survivors of sexual violence\, to developing a telemedicine platform for connecting doctors in rural areas with specialists worldwide. Dr. Liu remains a practicing doctor\, both in the field with MSF and also through hospital shifts in her home town of Montreal. She is currently a Professor at the School of Population and Global Health at McGill University with a focus on pandemic preparedness and response and health emergencies. \nLeonard Rubenstein\, Professor of the Practice\, Johns Hopkins Bloomberg School of Public Health \nProf. Leonard Rubenstein is Professor of the Practice at the Johns Hopkins Bloomberg School of Public Health\, and Director of the Program in Human Rights\, Health and Conflict. He is also a core faculty member the Berman\nInstitute of Bioethics and the Center for Humanitarian Health at Johns Hopkins University. Prior to coming to Johns Hopkins in 2009\, he was a Jennings Randolph Senior Fellow at the United States Institute of Peace\, and\nbefore that Executive Director and then President of Physicians for Human Rights. He has a J.D. from Harvard Law School and LL.M. from Georgetown Law School. He is a member of the Council on Foreign Relations. He is the recipient of numerous awards\, including the Congressional Minority Caucuses’ Healthcare Hero Award and the Sidel-Levy Award for Peace of the American Public Health Association. He has appeared before Congress\, the World Health Assembly and the UN Security Council. \nRobert Lawrence (Moderator)\, Center for a Livable Future Professor Emeritus\, John Hopkins Bloomberg School of Public Health and member of the National Academy of Medicine \nRobert Lawrence is the Center for a Livable Future Professor Emeritus and Professor Emeritus of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health and Professor Emeritus of\nMedicine at the Johns Hopkins School of Medicine. Dr. Lawrence graduated from Harvard Medical School\, trained in Internal Medicine at the Massachusetts General Hospital in Boston\, and served for three years as an Epidemic Intelligence Service Officer\, Centers for Disease Control and Prevention. At the University of North Carolina and as director of the Division of Primary Care at Harvard Medical School and chief of Medicine at the Cambridge Hospital\, he helped develop community health service and training programs. \nDr. Lawrence chaired the first U.S. Preventive Services Task Force from 1984-89 and served on the successor Task Force from 1990-96. From 1991 to 1995\, he served as Director of Health Sciences at the Rockefeller Foundation. He served as associate dean for professional education and programs at JHBSPH from 1995-2006\, established the Center for a Livable Future in 1996\, and served as its director until 2015. As a founding member of Physicians for Human Rights and former member of the Board of Directors\, Dr. Lawrence has participated in human rights investigations on behalf of PHR or other human rights groups to Chile\, Czechoslovakia\, Egypt\, El Salvador\, Guatemala\, the Philippines\, South Africa\, and Kosovo. He is a member of the National Academy of Medicine of the National Academy of Sciences \nPlease visit NASEM’s Protecting Health Care in Zones of Conflict: A Webinar project page for more information. Register on Eventbrite here.
URL:https://globalbiodefense.com/event/protecting-health-care-in-zones-of-conflict-a-webinar/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211019T120000
DTEND;TZID=America/New_York:20211019T133000
DTSTAMP:20210925T154740Z
CREATED:20210925T154620Z
LAST-MODIFIED:20210925T154740Z
UID:49829-1634644800-1634650200@globalbiodefense.com
SUMMARY:Opportunities & Challenges for Next Generation Sequencing of SARS-CoV-2
DESCRIPTION:Dr. Natalie Prystajecky explores how the various public health applications of sequencing has played a crucial role in outbreak response\, surveillance\, emerging variant detection\, and more during the COVID-19 pandemic. \nThis free event is brought to you by the 2021 ASM Clinical Virology Symposium (CVS)\, one of a 4-part CVS Online: SARS-CoV-2 Webinar Series featuring leading experts in the field discussing the most pressing topics around COVID-19. \nABOUT THE SPEAKER \nNatalie Prystajecky\, Ph.D.\nBCCDC Public Health Laboratory \nNatalie Prystajecky\, Ph.D. is a microbiologist at the British Columbia CDC Public Health Laboratory (BCCDC PHL)\, where she oversees the Environmental Microbiology and the Molecular and Microbial Genomics laboratories. She is also Clinical Associate Professor in Pathology and Laboratory Medicine at the University of British Columbia. \nIn her clinical roles and research endeavours\, she uses emerging technologies\, such as genomics\, to improve routine surveillance and outbreak investigations. During the COVID-19 pandemic\, she has provided leadership at the BCCDC PHL to implement genomics and explore opportunities and challenges for next generation sequencing of SARS-CoV-2. \nThis virtual event is open to ASM members and non-members. Registration opens Tuesday\, Sept. 28\, 2021.
URL:https://globalbiodefense.com/event/opportunities-challenges-for-next-generation-sequencing-of-sars-cov-2/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211020T100000
DTEND;TZID=America/New_York:20211021T170000
DTSTAMP:20210925T181613Z
CREATED:20210925T181613Z
LAST-MODIFIED:20210925T181613Z
UID:49859-1634724000-1634835600@globalbiodefense.com
SUMMARY:Advisory Committee on Immunization Practices (ACIP) Meeting
DESCRIPTION:The CDC Advisory Committee on Immunization Practices will convene 20-21 October 2021. ACIP typically holds three meetings each year at CDC in Atlanta\, Georgia to make vaccine recommendations. Due to the coronavirus disease 2019 (COVID-19) pandemic\, ACIP meetings have been held more frequently and have been virtual only (no in-person attendance). \nThe agenda will include discussions on adult immunization schedule\, child/adolescent immunization schedule\, Ebola vaccine\, hepatitis vaccines\, herpes zoster vaccines\, Orthopoxviruses vaccine\, influenza vaccines\, pneumococcal vaccine\, cholera vaccine and tickborne encephalitis vaccine. Recommendation votes on adult immunization schedule\, child/adolescent immunization schedule\, hepatitis vaccine\, herpes zoster vaccine\, Orthopoxviruses vaccine\, pneumococcal vaccine and Ebola vaccine are scheduled. No Vaccines for Children votes are scheduled. Agenda items are subject to change as priorities dictate. For more information on the meeting agenda visit https://www.cdc.gov/​vaccines/​acip/​meetings/​meetings-info.html. \nPublic Participation\nInterested persons or organizations are invited to participate by submitting written views\, recommendations\, and data. Please note that comments received\, including attachments and other supporting materials\, are part of the public record and are subject to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore\, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name\, contact information\, or other information that identifies you in the body of your comments\, that information will be on public display. CDC will review all submissions and may choose to redact\, or withhold\, submissions containing private or proprietary information such as Social Security numbers\, medical information\, inappropriate language\, or duplicate/near duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket. \nWritten Public Comment: The docket will be opened to receive written comments on October 1\, 2021. Written comments must be received on or before October 21\, 2021. \nOral Public Comment: This meeting will include time for members of the public to make an oral comment. Oral public comment will occur before any scheduled votes including all votes relevant to the ACIP’s Affordable Care Act and Vaccines for Children Program roles. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below. \nProcedure for Oral Public Comment: All persons interested in making an oral public comment at the October 20-21\, 2021 ACIP meeting must submit a request at http://www.cdc.gov/​vaccines/​acip/​meetings/​no later than 11:59 p.m.\, EDT\, October 18\, 2021\, according to the instructions provided. \nIf the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time\, CDC will conduct a lottery to determine the speakers for the scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email by October 19\, 2021. To accommodate the significant interest in participation in the oral public comment session of ACIP meetings\, each speaker will be limited to 3 minutes\, and each speaker may only speak once per meeting. \nThe Director\, Strategic Business Initiatives Unit\, Office of the Chief Operating Officer\, Centers for Disease Control and Prevention\, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities\, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. \nACIP consists of 15 experts who are voting members and are responsible for making vaccine recommendations. The Secretary of the U.S. Department of Health and Human Services (DHHS) selects these members after an application and nomination process. Fourteen of these members have expertise in vaccinology\, immunology\, pediatrics\, internal medicine\, nursing\, family medicine\, virology\, public health\, infectious diseases\, or preventive medicine. One member is a consumer representative who provides perspectives on the social and community aspects of vaccination. \nAll of ACIP’s recommendations are posted online. Once they are reviewed and approved by the CDC Director and Department of Health and Human Services\, recommendations are published in the CDC’s MMWR. \nThe MMWR publication represents the official CDC recommendations for immunizations of the U.S. population.
URL:https://globalbiodefense.com/event/advisory-committee-on-immunization-practices-acip-meeting/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211020T190000
DTEND;TZID=America/New_York:20211020T200000
DTSTAMP:20210924T220035Z
CREATED:20210924T214331Z
LAST-MODIFIED:20210924T220035Z
UID:49780-1634756400-1634760000@globalbiodefense.com
SUMMARY:Roundtable on Genomics and Precision Health - Community Open House
DESCRIPTION:The National Academies’ Roundtable on Genomics and Precision Health will host a community open house as an ancillary event to the American Society of Human Genetics 2021 Annual Meeting. Speakers will provide remarks on the Roundtable’s vision of realizing the full potential of health for all through genomics and explore how equity can enable adoption and innovation. Following speaker presentations\, the group will host an open dialogue with the genomics and precision health community. \nBackground \nThe Roundtable on Genomics and Precision Health (previously called the Roundtable on Translating Genomic-Based Research for Health) brings together leaders from government\, academia\, industry\, foundations\, associations\, patient communities\, and other stakeholder groups to meet and discuss global issues surrounding the translation of genomics and genetics research findings into medicine\, public health\, education\, and policy. The primary purpose of the Roundtable is to foster dialogue across sectors and among interested parties and institutions\, and to illuminate and scrutinize critical scientific and policy issues where Roundtable engagement and input will help further the field. \nThe Roundtable membership identifies scientific and policy issues where discussion and collaboration will help enable the translation of genomics into health care applications. Specific issues and agenda topics are determined by the Roundtable members\, and span a broad range of issues relevant to the translation process. Current areas of emphasis include the development of targeted therapeutics and diagnostics\, clinical implementation of genomic medicine\, health IT and mhealth\, the use of genomic information for health care decision making\, next generation sequencing\, using genomic information and data science to generate knowledge for clinical practice and research\, and education and ethical\, legal\, and social issues. \nTo achieve its objectives\, the Roundtable conducts structured discussions\, public workshops\, and symposia and enters into information-gathering activities\, develops authored perspectives\, organizes collaboratives\, and publishes workshop summaries. \nPlease visit NASEM’s Roundtable on Genomics and Precision Health – Community Open House page for more information.
URL:https://globalbiodefense.com/event/roundtable-on-genomics-and-precision-health-community-open-house/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211021T080000
DTEND;TZID=America/New_York:20211021T100000
DTSTAMP:20210924T231333Z
CREATED:20210924T231333Z
LAST-MODIFIED:20210924T231333Z
UID:49791-1634803200-1634810400@globalbiodefense.com
SUMMARY:Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication: Committee Meeting 4
DESCRIPTION:In this fourth meeting of the committee on Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication\, the committee will meet in closed session to discuss the structure and content of the report\, and will establish a plan for the committee’s activities moving forward. \nInaccurate and misleading information during infectious disease outbreaks have become commonplace\, presenting challenges to effective outbreak control\, seeding distrust among affected populations in foreign response activities\, and eliciting questions among security experts about the true origins of outbreaks. Some false claims may be disproven through sound scientific analysis\, suggesting a role for scientists to provide evidence-based\, scientifically defensible information to refute such claims. The National Academies are evaluating how to enable long-term engagement of scientists internationally to identify and address claims about biological threats that emerge from or are perpetuated by inaccurate and misleading information. \nAs part of this evaluation\, the committee will suggest a community engagement strategy for developing an international network of scientists to address claims about biological threats resulting from inaccurate and misleading information. Specifically\, this activity will: \n\nEvaluate existing online platforms and virtual communities for sharing information about and analyzing data from biological events including emerging outbreaks\, and current approaches for community-based review of scientific publications\, blog posts\, and other materials in this topical area.\nExplore key considerations for developing an international community or network of scientists to address the veracity of claims relating to biological threats. Considerations may include evaluation of the scientific qualifications of participants\, the accuracy and objectivity of analytic results\, transparency and integrity of analyses and peer review\, protection of scientists seeking to contribute to the community\, sustainability of the community\, and communication of scientific results.\nIncorporate knowledge from social and behavioral science fields in addressing network development and influence\, and community-based interactions in online settings.\nDevelop a community engagement strategy for establishing an international network of scientists to evaluate the credibility of reported biological threats. The strategy would incorporate lessons observed from existing platforms and approaches\, and include suggestions for organizational structures\, hosts and sustainability.\n\nThis project will involve the production of a short consensus report that will summarize the study findings and the suggested engagement strategy. The report and strategy to develop the network will be directed toward organizations involved in bioengagement activities and/or the broader scientific community. \nSubmit Input: Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication \nSubmit your ideas to the National Academies’ study on Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication.  More information can be found on the study webpage.
URL:https://globalbiodefense.com/event/addressing-inaccurate-and-misleading-information-about-biological-threats-through-scientific-collaboration-and-communication-committee-meeting-4/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211021T120000
DTEND;TZID=America/Los_Angeles:20211021T133000
DTSTAMP:20210925T160602Z
CREATED:20210925T160602Z
LAST-MODIFIED:20210925T160602Z
UID:49832-1634817600-1634823000@globalbiodefense.com
SUMMARY:General Overview of Approaches to Treatment & Prevention of SARS-CoV-2/COVID-19
DESCRIPTION:Dr. Cheston Cunha takes a deep dive into how clinicians and scientists approach the treatment and prevention of SARS-CoV-2 during the global pandemic. \nThis free event is brought to you by the 2021 ASM Clinical Virology Symposium (CVS)\, one of a 4-part CVS Online: SARS-CoV-2 Webinar Series featuring leading experts in the field discussing the most pressing topics around COVID-19. \nParticipants will be able to ask questions during this live Q&A. \nABOUT THE SPEAKER \nCheston Cunha\, M.D.\nRhode Island Hospital \nCheston Cunha\, M.D. is the Medical Director of the Rhode Island Hospital and Miriam Hospital Antimicrobial Stewardship Program. He acts as an associate program director for the Infectious Disease Fellowship at Brown and Co-Course Leader of the Medical Student Infectious Disease Course. He is also assistant professor of medicine at Brown University Alpert School of Medicine. He has received the Dean’s Excellence in Teaching award from the Alpert Medical School of Brown University on numerous occasions\, as well as the Beckwith Family Teaching Award and the Steven Opal Teaching Award. He has contributed over 45 articles and 65 book chapters to the medical literature. He serves as editor of the books: Antibiotic Essentials\, Antimicrobial Stewardship: Principles & Practice\, Infectious Diseases and Antimicrobial Stewardship in Critical Care Medicine and Schlossberg’s Clinical Infectious Disease. \nThis virtual event is open to ASM members and non-members. Registration opens Tuesday\, Sept. 28\, 2021.
URL:https://globalbiodefense.com/event/general-overview-of-approaches-to-treatment-prevention-of-sars-cov-2-covid-19/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211021T163000
DTEND;TZID=America/New_York:20211021T174500
DTSTAMP:20210925T041245Z
CREATED:20210925T041203Z
LAST-MODIFIED:20210925T041245Z
UID:49814-1634833800-1634838300@globalbiodefense.com
SUMMARY:The Next Normal: Civil Liberties and Health
DESCRIPTION:Many conversations surrounding the COVID-19 pandemic were framed as a trade-off between individual liberties and the health of the public. Was this the right framing? What are the implications of the moment for future conversations? \nThis program is a part of “The Next Normal” series\, designed to take a moment to pause and ask\, as we emerge from the pandemic\, what we have learned and why\, in order to promote the health of all\, we cannot return to pre-pandemic normal. \nSPEAKERS \nNancy Berlinger\, Research Scholar\, The Hastings Center \nNancy Berlinger is a Research Scholar at The Hastings Center\, an independent bioethics research institute based in Garrison\, NY. Her current research focuses on ethical and societal challenges arising from population aging; the bioethics of migration\, and responding to and learning from the Covid-19 pandemic. She has longstanding research interests in decision-making and care in serious illness and near the end of life; the management of problems of safety and harm in health systems\, and the moral dimensions of care work. She directs The Hastings Center’s Visiting Scholar Program\, including the Sadler Scholars Program for doctoral students from underrepresented communities\, here. \nColleen Flood\, Professor and University Research Chair\, University of Ottawa \nColleen M. Flood is a Professor in the Faculty of Law at the University of Ottawa and University Research Chair in Health Law & Policy.  In addition\, she serves as the inaugural director of the university’s Centre for Health Law\, Policy and Ethics.  From 2006-2011\, she was also a Scientific Director of the Institute for Health Services and Policy Research\, one of the Canadian Institutes of Health Research. From 2012 to 2016\, she served on the governance board of the Institute for Clinical Evaluative Sciences. She is currently on the board of Associated Medical Services and a member of the Corporation of Massey College. Professor Flood has received several honours and distinctions for her work. Most recently\, she was elected as a fellow of the Royal Society of Canada. In 2013\, she was appointed an honorary member of the College of Family Physicians of Ontario. \nRuqaiijah Yearby\, Professor of Law and Executive Director and CO- Founder\, Institute for Healing Justice and Equity\, Saint Louis University \nRuqaiijah Yearby\, J.D.\, M.P.H is a full professor and member of the Center for Health Law Studies at Saint Louis University School of Law. She is also co-founder and Executive Director of Saint Louis University’s Institute for Healing Justice and Equity and Co-Principal Investigator for the Robert Wood Johnson Foundation grant entitled\, “Are Cities and Counties Ready to Use Racial Equity Tools to Influence Policy?”. Additionally\, she has served as an Instructor for the Harvard Medical School\, Center for Bioethics. \nProfessor Ruqaiijah Yearby is an expert in racial health disparities\, who advocates for equal access to quality health care and fair wages for racial and ethnic minorities\, women\, and the poor. Recently\, Professor Yearby authored Protecting Workers that Provide Essential Services and co-authored Racism is a Public Health Crisis. Here’s How to Respond\, which was used to support the passage of Connecticut House Bill No. 6662\, that declares racism as a public health crisis as well as cited in the American Psychological Association Resolution to Combat Racism and in the 2020 Health Equity report for Boone County\, MO. Her work has been published in the American Journal of Bioethics\, Health Affairs\, and the Oxford Journal of Law and the Biosciences and used in law\, medical school\, and social science classes at schools such as Harvard\, NYU\, Fordham\, and the University of California Berkeley. \nShe earned her B.S. in Honors Biology from the University of Michigan\, M.P.H. from Johns Hopkins School of Public Health\, and her J.D. from Georgetown University Law Center. She worked at the U.S. Department of Health and Human Services as an Assistant Regional Counsel and served as a law clerk for the Honorable Ann Claire Williams of the U.S. Court of Appeals for the Seventh Circuit. \nChantal Da Silva\, MODERATOR\, Chief Correspondent\, Newsweek \nChantal Da Silva is a freelance journalist working for NBC News. Her work has been featured by Newsweek\, where she previously served as chief correspondent\, as well as by CNN\, The Independent\, Forbes\, The Bureau of Investigative Journalism\, The Guardian and others. \n 
URL:https://globalbiodefense.com/event/the-next-normal-civil-liberties-and-health/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://bostonu.zoom.us/webinar/register/WN_ZIQvqxJBQB27BWH78CFX9w
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211021T183000
DTEND;TZID=America/New_York:20211021T193000
DTSTAMP:20240118T180249Z
CREATED:20210930T221850Z
LAST-MODIFIED:20240118T180249Z
UID:49961-1634841000-1634844600@globalbiodefense.com
SUMMARY:Schar School of Policy and Government: Master’s and Certificate Virtual Open House
DESCRIPTION:Learn more about the Schar School of Policy and Government’s Biodefense Program\, offering in-person and online options. \nThe George Mason University (GMU) Schar School of Policy and Government will host a Master’s Open House on October 21\, 2021 at 6:30pm Eastern. \nYou’re invited to attend this virtual open house to learn more about the Schar School of Policy and Government and their academic programs. The online session will provide an overview of their master’s degree programs and graduate certificate programs\, student services\, and admissions requirements. \nAdmissions and student services staff will be on hand to answer questions. \nPlease visit the Schar School Master’s and Certificate Open House website for more information and to register today.
URL:https://globalbiodefense.com/event/schar-school-of-policy-and-government-masters-and-certificate-virtual-open-house-2/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2021/09/gmu-schar-school-biodefense-program-open-house-virtual-oct-21.png
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211024
DTEND;VALUE=DATE:20211025
DTSTAMP:20210925T173226Z
CREATED:20210925T173102Z
LAST-MODIFIED:20210925T173226Z
UID:49853-1635033600-1635119999@globalbiodefense.com
SUMMARY:World Polio Day
DESCRIPTION:Join us on October 24 for World Polio Day to share the progress of health experts and partners on the road to polio eradication. \nPoliomyelitis\, or polio\, is a paralyzing and potentially fatal disease that still threatens children in some parts of the world. Poliovirus invades the nervous system and can cause total paralysis in hours. It can strike people of any age but mainly affects children under five. Polio can be prevented by vaccines\, but it is not curable. Unlike most diseases\, polio can be eradicated. \nPoliomyelitis\, or polio\, is a paralyzing and potentially fatal disease that still threatens children in some parts of the world. Poliovirus invades the nervous system and can cause total paralysis in hours. It can strike people of any age but mainly affects children under five. Polio can be prevented by vaccines\, but it is not curable. Unlike most diseases\, polio can be eradicated. \nAt the end of the 1980s\, more than 350\,000 children were paralyzed by polio every year. Today\, Rotary and its partners have reduced the incidence of polio by 99.9 percent. However\, until we see the last of the poliovirus\, eradication efforts need additional funding to: \n\nIMMUNIZE more than 400 million children against polio every year\nIMPROVE disease surveillance systems to detect any poliovirus in a person or the environment\nHIRE more than 150\,000 health workers to go door to door to find every child\n\nLearn more about how to take action and participate on World Polio Day at the Rotary website. \n 
URL:https://globalbiodefense.com/event/world-polio-day/
LOCATION:Global Biodefense Calendar
CATEGORIES:Awareness Event,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/09/end-polio-now-world-polio-day-rotary.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211026
DTEND;VALUE=DATE:20211027
DTSTAMP:20211004T010523Z
CREATED:20211004T010523Z
LAST-MODIFIED:20211004T010523Z
UID:50037-1635206400-1635292799@globalbiodefense.com
SUMMARY:VRBPAC Meeting on Pfizer Data on Its COVID-19 Vaccine for Children 5-11
DESCRIPTION:The FDA anticipates receiving a request from Pfizer to amend its emergency use authorization to allow the use of its COVID-19 vaccine in children 5 through 11 years of age. In anticipation of the request\, the FDA is scheduling an Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting on Oct. 26 to inform the agency’s decision-making. \nThe FDA intends to make background materials for both VRBPAC meetings available to the public\, including the meeting agendas and committee rosters\, no later than two business days before each meeting. \nThe FDA intends to livestream the VRBPAC meetings on the agency’s YouTube page.
URL:https://globalbiodefense.com/event/vrbpac-meeting-on-pfizer-data-on-its-covid-19-vaccine-for-children-5-11/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/10/fda-vrbpac-covid-vaccine-children-meeting-oct-2021.jpg
LOCATION:https://www.youtube.com/watch?v=laaL0_xKmmA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211027
DTEND;VALUE=DATE:20211030
DTSTAMP:20210923T213854Z
CREATED:20210923T213854Z
LAST-MODIFIED:20210923T213854Z
UID:49719-1635292800-1635551999@globalbiodefense.com
SUMMARY:GET Africa - Global Emerging Pathogens Treatment Consortium
DESCRIPTION:The 7th African Conference on One Health and Biosecurity  – GET Africa 2021 – will be held 27-29 October 2021 in Lagos\, Nigeria. \nGET was established in 2014 as a direct response to the 2014-16 Ebola virus disease outbreak in West Africa and ongoing outbreaks of Lassa Fever\, Meningitis\, Multidrug resistance (MDR) enteric fevers and Yellow Fever across the sub region. \n 
URL:https://globalbiodefense.com/event/get-africa-global-emerging-pathogens-treatment-consortium/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211028
DTEND;VALUE=DATE:20211030
DTSTAMP:20210924T224008Z
CREATED:20210924T224008Z
LAST-MODIFIED:20210924T224008Z
UID:49789-1635379200-1635551999@globalbiodefense.com
SUMMARY:Innovations in Pharmaceutical Manufacturing on the Horizon: A Virtual Dissemination Workshop
DESCRIPTION:Emerging technologies have the potential to modernize pharmaceutical manufacturing and advance the quality of drug products. \nThe National Academies of Sciences\, Engineering\, and Medicine; Division on Earth and Life Studies; Board on Chemical Sciences and Technology; Committee to Identify Innovative Technologies to Advance Pharmaceutical Manufacturing released a report which identifies these innovative technologies\, including manufacturing processes\, control and testing strategies\, and product technologies. \nThe report\, sponsored by the Food and Drug Administration Center for Drug Evaluation and Research\, also discusses technical and regulatory challenges to implementing these technologies and provides suggestions for how to overcome regulatory challenges. Join us for an upcoming virtual workshop where the pharmaceutical manufacturing community will discuss the report recommendations and strategies to advance the field. \nPlease visit NASEM’s Innovations in Pharmaceutical Manufacturing on the Horizon: A Virtual Dissemination Workshop website for more information. \n 
URL:https://globalbiodefense.com/event/innovations-in-pharmaceutical-manufacturing-on-the-horizon-a-virtual-dissemination-workshop/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211028T080000
DTEND;TZID=America/New_York:20211028T100000
DTSTAMP:20210924T231919Z
CREATED:20210924T231858Z
LAST-MODIFIED:20210924T231919Z
UID:49793-1635408000-1635415200@globalbiodefense.com
SUMMARY:Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication: Committee Meeting 5
DESCRIPTION:In this fifth meeting of the committee on Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication\, the committee will meet in closed session to discuss the structure and content of the report\, and will establish a plan for the committee’s activities moving forward.\n\n\n\nAs part of this evaluation\, the committee will suggest a community engagement strategy for developing an international network of scientists to address claims about biological threats resulting from inaccurate and misleading information. Specifically\, this activity will: \n\nEvaluate existing online platforms and virtual communities for sharing information about and analyzing data from biological events including emerging outbreaks\, and current approaches for community-based review of scientific publications\, blog posts\, and other materials in this topical area.\nExplore key considerations for developing an international community or network of scientists to address the veracity of claims relating to biological threats. Considerations may include evaluation of the scientific qualifications of participants\, the accuracy and objectivity of analytic results\, transparency and integrity of analyses and peer review\, protection of scientists seeking to contribute to the community\, sustainability of the community\, and communication of scientific results.\nIncorporate knowledge from social and behavioral science fields in addressing network development and influence\, and community-based interactions in online settings.\nDevelop a community engagement strategy for establishing an international network of scientists to evaluate the credibility of reported biological threats. The strategy would incorporate lessons observed from existing platforms and approaches\, and include suggestions for organizational structures\, hosts and sustainability.\n\nThis project will involve the production of a short consensus report that will summarize the study findings and the suggested engagement strategy. The report and strategy to develop the network will be directed toward organizations involved in bioengagement activities and/or the broader scientific community. \nSubmit Input: Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication \nSubmit your ideas to the National Academies’ study on Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication.  More information can be found on the study webpage.
URL:https://globalbiodefense.com/event/addressing-inaccurate-and-misleading-information-about-biological-threats-through-scientific-collaboration-and-communication-committee-meeting-5/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211028T140000
DTEND;TZID=America/New_York:20211028T150000
DTSTAMP:20210226T162359Z
CREATED:20210226T162359Z
LAST-MODIFIED:20210226T162359Z
UID:48675-1635429600-1635433200@globalbiodefense.com
SUMMARY:A Family Drama: The Sexual Politics of Smallpox Vaccination in the Spanish Empire
DESCRIPTION:The National Institutes of Health COVID-19 Scientific Interest Group will host a webcast entitled “A Family Drama: The Sexual Politics of Smallpox Vaccination in the Spanish Empire” on October 28\, 2021. \nIn 1804\, the Spanish Crown introduced the smallpox vaccine to its empire\, along with orders that vaccination be voluntary and that parents had a right to consent. Yet as families weighed the meaning of this decision\, doctors turned to the slave trade\, securing the vaccine and its future through bondage. \nAnalyzing this polemic and the politicization of preventative health\, my talk draws on collections of the NLM History of Medicine Division\, including institutional regulations and vaccination rosters from the Spanish Americas\, to trace the vaccine through the greater Caribbean and ask how and why colonial authorities selectively protected voluntary vaccination. \nForegrounding the methods by which the Spanish sought parental consent\, I examine the expectations about parenthood\, childrearing\, and the family that underscored their efforts\, demonstrating how long-standing investments in a patriarchal familial order were reanimated through the conservation and dissemination of the vaccine. In doing so\, the talk highlights the racial and sexual politics of vaccination and its contested relationship to slavery\, freedom\, and motherhood in the Atlantic World. \nAbout the Speaker \nFarren Yero\, PhD\, Postdoctoral Associate\, Gender\, Sexuality\, and Feminist Studies\, Duke University\, NIH \nPlease visit the NIH VideoCast website for more information.
URL:https://globalbiodefense.com/event/a-family-drama-the-sexual-politics-of-smallpox-vaccination-in-the-spanish-empire/
CATEGORIES:Webinar-Webcast
LOCATION:https://videocast.nih.gov/watch=41228
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211029T110000
DTEND;TZID=America/Los_Angeles:20211029T120000
DTSTAMP:20210925T161513Z
CREATED:20210925T161423Z
LAST-MODIFIED:20210925T161513Z
UID:49834-1635505200-1635508800@globalbiodefense.com
SUMMARY:Vaccine Hesitancy and the Anti-Vaxxer Movement
DESCRIPTION:Dr. Peter Hotez weighs in on identifying innovative strategies to tackling vaccine hesitancy and the anti-science movement. \nThis free event is brought to you by the 2021 ASM Clinical Virology Symposium (CVS)\, one of a 4-part CVS Online: SARS-CoV-2 Webinar Series featuring leading experts in the field discussing the most pressing topics around COVID-19. \nABOUT THE SPEAKER \nPeter Hotez\, M.D.\, Ph.D.\nBaylor College of Medicine \nPeter J. Hotez\, M.D.\, Ph.D. is Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine. He is also the Co-Director of the Texas Children’s Center for Vaccine Development (CVD) and Texas Children’s Hospital Endowed Chair of Tropical Pediatrics.  He is also University Professor at Baylor University\, Fellow in Disease and Poverty at the James A Baker III Institute for Public Policy\,  Senior Fellow at the Scowcroft Institute of International Affairs at Texas A&M University\, Faculty Fellow with the Hagler Institute for Advanced Studies at Texas A&M University\, and Health Policy Scholar in the Baylor Center for Medical Ethics and Health Policy. He is the author of Forgotten People\, Forgotten Diseases (ASM Press/Wiley). \nThis virtual event is open to ASM members and non-members. Registration opens Tuesday\, Sept. 28\, 2021.
URL:https://globalbiodefense.com/event/vaccine-hesitancy-and-the-anti-vaxxer-movement/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211101
DTEND;VALUE=DATE:20211104
DTSTAMP:20210930T162552Z
CREATED:20210930T162552Z
LAST-MODIFIED:20210930T162552Z
UID:49950-1635724800-1635983999@globalbiodefense.com
SUMMARY:Africa CDC Inaugural One Health Conference
DESCRIPTION:The Africa CDC Inaugural One Health Conference taking place virtually from 1 – 3 November 2021. \nOne Health is a collaborative\, multisectoral and transdisciplinary approach used to attain optimal health outcomes for people\, animals\, plants\, and their shared environment. Practically\, One Health involves the collaboration between human\, animal\, and environmental health sectors as well as other relevant stakeholders\, in the design and implementation of programmes\, policies\, legislation\, and research intended to achieve better health outcomes for all. \nTo celebrate and share the various One Health work taking place on the continent\, the Africa Centres for Disease Control and Prevention (Africa CDC) is hosting a 3-day virtual One Health Conference from 1-3 November 2021. The conference aims to: \n\nShare best practices and experiences from Member States and partners.\nShowcase continental One Health research focusing on zoonotic disease surveillance and outbreak investigations\, antimicrobial resistance\, food safety\, environmental health\, and operational research through scientific presentations.\nHighlight operational tools and guidance documents developed by African Union organs and technical partners like WHO\, OIE and FAO.\nExhibit opportunities for collaboration or One Health implementation support.\nStrengthen One Health advocacy and capacity across the AU Member States and Regional networks.\n\nPresenters will include representatives from Africa Union Member States\, RECs\, Africa Union technical agencies\, Africa CDC RCCs\, research institutions and technical partners. \nThis conference is hosted by Africa CDC in association with SBS Conferences & Exhibitions. \nQueries may be directed to info@sbs.co.za or +27 (0)71 348 1780. Registration is FREE and open to anyone interested in or involved in the field of One Health on the African continent. \nPlease visit the Africa CDC Inaugural One Health Conference website for more information. \n 
URL:https://globalbiodefense.com/event/africa-cdc-inaugural-one-health-conference/
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2021/09/africa-cdc-one-health-conference.png
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211101
DTEND;VALUE=DATE:20211105
DTSTAMP:20210924T232710Z
CREATED:20210924T232546Z
LAST-MODIFIED:20210924T232710Z
UID:49795-1635724800-1636070399@globalbiodefense.com
SUMMARY:Eighth Arab-American Frontiers of Science\, Engineering\, and Medicine Symposium
DESCRIPTION:The Arab-American Frontiers program brings together outstanding young scientists\, engineers\, and medical professionals from the United States and the 22 countries of the Arab League for a series of symposia to discuss exciting advances and opportunities in their fields. \nDue to ongoing concerns surrounding the new COVID-19 variant\, the Eighth Symposium will now take place online\, November 1-4\, 2021. \nThe goal of these meetings is to enhance the scientific exchange and dialogue among young researchers in Arab countries and the United States\, including the Arab science diaspora\, and through this interaction\, facilitate research collaboration within and beyond the region. \nThe eighth symposium will discuss advances across a broad range of multi-disciplinary topics through five plenary sessions. These sessions are: \n\nSession I: Advanced Materials\nSession II: e-Health\nSession III: Water\, Food\, Environment\nSession IV: Cybersecurity\nSession V: Emerging Technologies and Society\n\nHighlighted topics include: \n\nApplying Patient and Public Health Data for Pandemic Response and Health Security (TBC)\nFrom Drones to Dentures: How Novel Materials are Increasing the Adoption of 3d Printing Across Every Industry\nApplications of Smart Wearable Devices in Health: Data\, Policy\, and Security Considerations\n\nThis symposium is made possible by the generous support of USAID\, Hamad bin Khalifa University\, and the National Science Foundation.
URL:https://globalbiodefense.com/event/eighth-arab-american-frontiers-of-science-engineering-and-medicine-symposium/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211103
DTEND;VALUE=DATE:20211105
DTSTAMP:20210812T192722Z
CREATED:20210812T192722Z
LAST-MODIFIED:20210812T192722Z
UID:49489-1635897600-1636070399@globalbiodefense.com
SUMMARY:BARDA Industry Day 2021 – BID2021
DESCRIPTION:This BARDA Industry Day 2021 Virtual Event will be held 3-4 November 2021. \nThis annual gathering of more than 1300 stakeholders from the public and private sector provides an opportunity to increase understanding of the U.S. government medical countermeasure priorities and funding goals; interact with BARDA and ASPR staff; and showcase innovations. \nInnovators may apply for limited openings to present during Lightning Talks sessions. Lightning Talks are for individuals\, academic institutions\, pharmaceutical companies\, biotech\, and other industry innovators to showcase their innovative technologies. \nTo submit your application for the Lightning Talks\, please enter the requested information and provide a brief (maximum 500 words) summary of your proposed presentation\, with one optional PowerPoint slide\, by 16 August. \nVisit the BARDA Industry Day website for more information. \n  \n 
URL:https://globalbiodefense.com/event/barda-industry-day-2021-bid2021/
CATEGORIES:Conference,Government Hosted,Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/08/bid-2021-barda-industry-day.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211104
DTEND;VALUE=DATE:20211106
DTSTAMP:20211014T233809Z
CREATED:20211014T233450Z
LAST-MODIFIED:20211014T233809Z
UID:50256-1635984000-1636156799@globalbiodefense.com
SUMMARY:NIH 2021 Synthetic Biology Consortium
DESCRIPTION:The 2021 Annual Synthetic Biology Consortium Meeting will take place in virtual format from November 4-5\, 2021. \nThe 2021 Synthetic Biology Consortium Meeting will facilitate networking and collaboration among synthetic biology investigators. Attendees can use this meeting to collaborate with each other on current topics in synthetic biology and engage with NIH program directors. \nHighlighted presenters and panelists include: \n\nKaren Elkins\, FDA\, Center for Biologics Evaluation and Research\nMichelle Bond\, NIGMS\, Division of Pharmacology\, Physiology\, and Biological Chemistry\nTuba Fehr\, NICHD\, Development Biology and Structural Variation Branch\nTim Lu\, Massachusetts Institute of Technology\nGary Lee\, Senti Biosciences\nStephanie Morris\, NHGRI\, Division of Genome Sciences\nBrigitte Sanders\, NIAID\, Division of AIDS\nHye-Sook Kim\, NCCIH\, Basic and Mechanistic Research\nTatjana Atanasijevic\, NIBIB\, Division of Applied Science and Technology (Bioimaging)\nParijat Bhatnagar\, SRI International\nJoshua Leonard\, Northwestern University\nTara Deans\, The University of Utah\nDave Rampulla\, NIBIB\, Division of Discovery Science and Technology (Bioengineering)\nRahul Thakar\, NHLBI\, Advanced Technologies and Surgery Branch\nRyan Richardson\, NINDS\, Office of the BRAIN Director\nJerry Li\, NCI\, Structural Biology and Molecular Applications Branch\nKelly Crotty\, NCI\, Center for Strategic Scientific Initiatives\nJiahe Li\, Northeastern University\nTal Danino\, Columbia University\nAndrew Ellington\, University of Texas at Austin\nOphelia Venturelli\, University of Wisconsin-Madison\n\nPlease visit NIH’s 2021 Synthetic Biology Consortium meeting site for more information. \n 
URL:https://globalbiodefense.com/event/nih-2021-synthetic-biology-consortium/
CATEGORIES:Conference,Government Hosted,Webinar-Webcast
LOCATION:https://www.zoomgov.com/meeting/register/vJItfu-hpzIiHqmy-7yogDu9ImlF2Lfd0iE
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211105T090000
DTEND;TZID=America/New_York:20211105T101500
DTSTAMP:20211004T004515Z
CREATED:20211004T004515Z
LAST-MODIFIED:20211004T004515Z
UID:50031-1636102800-1636107300@globalbiodefense.com
SUMMARY:Allocating Scarce COVID-19 Vaccines Based on Epidemiological and Operational Considerations
DESCRIPTION:The Center for Global Development will host an online event on Allocating Scarce COVID-19 Vaccines Based on Epidemiological and Operational Considerations on 5 Nov 2021. \nSince the early days of the COVID-19 pandemic\, many institutes have been using epidemiological modelling to predict the spread of the novel coronavirus as well as estimate the impact of different control measures. \nWith the development of multiple vaccine candidates\, new questions have now arisen as to how policymakers can ensure cost-effective COVID-19 vaccine deployment and allocation that considers both operational constraints (e.g.\, in-country cold chain or human resources for healthcare capacity) and epidemiological characteristics (e.g.\, seroprevalence\, social mixing\, age-stratification\, comorbidities\, vaccine stretching etc). \nIn this event\, study groups will present and disseminate results that tackle a diverse range of research questions focusing on COVID19 vaccine deployment and allocation. A wider discussion will follow focussing on how decision makers can consider epidemiological and operational modelling evidence to inform cost-effective COVID-19 vaccine deployment and allocation and highlight potential future steps and generalisable lessons for many lower resource settings. \nPRESENTERS \n\nNimalan Arinaminpathy\, Professor in Mathematical Epidemiology\, Imperial College London\nSarang Deo\, Professor\, Indian School of Business\nSripad Devalkar\, Associate Professor of Operations Management\, Indian School of Business\n\nPlease visit the Allocating Scarce COVID-19 Vaccines Based on Epidemiological and Operational Considerations event site to register.
URL:https://globalbiodefense.com/event/allocating-scarce-covid-19-vaccines-based-on-epidemiological-and-operational-considerations/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:https://www.youtube.com/watch?v=fBrn7Ayos2U
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211108T120000
DTEND;TZID=America/New_York:20211108T150000
DTSTAMP:20210925T002112Z
CREATED:20210925T002112Z
LAST-MODIFIED:20210925T002112Z
UID:49797-1636372800-1636383600@globalbiodefense.com
SUMMARY:Impact of and Response to the Pandemic: Webinar 1
DESCRIPTION:The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care for People with Serious Illness will host a virtual workshop to provide a neutral venue for stakeholders in serious illness care to consider the lessons learned from the pandemic in order to continually improve care for people with serious illness in the future. \nThe virtual workshop will be held over three webinars in November. \n\n8 Nov  12:00 – 3:00PM: Impact of and Response to the Pandemic: Webinar 1\n18 Nov 12:00 – 3:00PM: Recovery and Resilience: Webinar 2\n30 Nov 1:00 – 3:30PM: Prevention and Preparedness: Webinar 3\n\n\nDescription\n\n\n\nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and host a 1.5-day public workshop to examine the impact of the COVID-19 pandemic on serious illness care and consider lessons learned and future directions\, with specific focus on health care access\, health equity\, and innovative responses to care in the context of  the pandemic. \nThe workshop will feature invited presentations and panel discussions on topics that may include: \nDelivery of person-centered\, family-oriented care \n\nKey role of palliative care teams during the pandemic\nRole of caregivers and impact on caregivers’ physical\, emotional and mental health\nSpecific learnings from different care models in various care settings (e.g.\, hospital-based palliative care\, care at home\, and in the community)\nUse of telehealth and impact on access to care\n\nClinician-Patient-Family communication and advance care planning \n\nUse of technology to connect family members to patients\nUse of serious illness communication guides to train non-palliative care specialist health care professionals\n\nProfessional education and development \n\nUse of technology support and remote applications to quickly train health care professionals\nCollaboration between palliative care teams and ICU/Emergency Department staff\n\nPolicies and payment systems \n\nTelehealth supported by flexibility in payment\nThe need for better alignment between health care and social care\n\nPublic education and engagement \n\nHow to communicate effectively and engage the public in advance care planning\nAddressing grief/bereavement on large scale in the U.S.\n\nThe planning committee will develop the agenda for the workshop\, select speakers and discussants\, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. \n\n\nPlease visit NASEM’s Caring for People with Serious Illness during the COVID-19 Pandemic: A Workshop on Lessons Learned and Future Directions site for more information.
URL:https://globalbiodefense.com/event/impact-of-and-response-to-the-pandemic-webinar-1/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211111
DTEND;VALUE=DATE:20211114
DTSTAMP:20210226T211932Z
CREATED:20210226T211804Z
LAST-MODIFIED:20210226T211932Z
UID:48685-1636588800-1636847999@globalbiodefense.com
SUMMARY:APCCMI 2021 - Asia Pacific Congress of Clinical Microbiology and Infection
DESCRIPTION:The APCCMI 2021 Asia Pacific Congress of Clinical Microbiology and Infection will take place 11-13 November 2021 in Singapore and through virtual offerings. \nAPCCMI is the biennial conference for the Asia Pacific Society of Clinical Microbiology and Infection (APSCMI). \nHighlighted topics include: \n\nMERS CoV\, avian influenza and other respiratory viruses\nTransplant infectious diseases\nAdvances in rapid diagnostics\nAdvances in influenza therapeutics\nOne Health in infectious diseases\nMalaria and vector borne infections\nHot topics in antimicrobial stewardship\nTuberculosis and mycobacteria\nUtility of genome sequencing\nClinical implications of microbiome\n\nWho should attend? \nInfectious disease doctors\, trainees and scientists\nClinical and laboratory microbiologists\nInfection control professionals including doctors\, nurses and epidemiologists\nOutbreak control professionals including doctors\, epidemiologists and policy makers\nPharmacists and pharmacologists\nScientists and students undertaking research in the related fields\nVaccine professionals including doctors\, nurses\, pharmacists and policy makers \nPlease visit the APCCMI 2021 website for more information.
URL:https://globalbiodefense.com/event/apccmi-2021-asia-pacific-congress-of-clinical-microbiology-and-infection/
LOCATION:Suntec Singapore Convention Centre\, 1 Raffles Boulevard\, Suntec City\, 039593\, Singapore
CATEGORIES:Conference
END:VEVENT
END:VCALENDAR